|
|
|
Clinical Research Detail |
|
|
|
Title Of Study |
This study is to evaluate the efficacy, safety, and tolerability of 2 different doses of canagliflozin administered as monotherapy compared with placebo in patients with type 2 diabetes mellitus (T2DM) inadequately controlled with diet and exercise
|
|
|
Disease Condition |
Diabetes Mellitus, Type 2
|
|
|
Phase of Trial |
Phase-3
|
Discipline |
Diabetology
|
|
|
Start date of Trial |
8/2/2010
|
Closing Date of Trial |
8/2/2012
|
|
|
|